logo
Plus   Neg
Share
Email

Sherwin-Williams To Take $77 Mln Charges In Q2 On DC Solar Investment

Sherwin-Williams Co. (SHW) said it will take a charge of about $77 million in the second quarter of 2019 to reflect the entire loss of the investment with DC Solar Solutions and related expected tax benefits. The company has determined that it is more likely than not that the tax benefits expected to be received by the company related to the investments will no longer be ultimately realizable.

The company said it invested in projects that support historic rehabilitation, affordable housing, and renewable energy. During 2011, and 2013 through 2017, the Company invested in federal renewable energy tax credit funds exclusively with DC Solar Solutions Inc. and certain of its affiliates related to mobile solar generators.

In December 2018, the company became aware of an ongoing investigation by federal authorities, which included the seizure of DC Solar's assets. The ompany promptly initiated an investigation, Sherwin-Williams said.

In February 2019, DC Solar filed for Chapter 11 (reorganization) bankruptcy protection, and the company learned of an affidavit from a special agent of the Federal Bureau of Investigation alleging that DC Solar was operating a fraudulent "Ponzi-like scheme" involving mobile solar generators sold to investors. In March 2019, the bankruptcy case was converted to Chapter 7 (liquidation).

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Retail Federation Chief Economist Jack Kleinhenz said it was too early to say how quickly or smoothly the U.S. economy would stage a recovery following the "sizable disruptions" due to the coronavirus pandemic. However, he noted that the reopening of businesses and the resumption of economic activity is a significant step forward. Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products. Hundreds of Facebook employees staged a "virtual walkout" on Monday to protest the company's decision not to act on recent controversial posts by President Donald Trump on the social media platform. The employees criticized Facebook chief executive Mark Zuckerberg's decision to not moderate a post from Trump last Thursday.
Follow RTT